Telix to Merge With Germany's ITM in Radiopharmaceutical Tie-Up
Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich, a private radioisotope producer that reported US$273 million of 2025 revenue.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.